At Yorhealthfirst Clinic We are here to help you manage your weight as safely and effectively as possible. Our Wimpole Street Weight Management Service is delivered exclusively by Trained and Experienced Doctors and Practitioners.
Discover a revolutionary way to lose weight with Mounjaro
Mounjaro is a weight loss injection designed to enhance fat reduction for fast, long lasting weight loss.
Experience the change with Mounjaro
You can buy Mounjaro online through our UK registered online prescribing service. Mounjaro is the latest GLP-1 weight loss injection available in the UK, and is the most effective. It has surpassed the effectiveness of Semaglutide (Ozempic + Wegovy), with patients seeing as much as 22.5% body weight loss.
You can order Mounjaro after completing an online assessment with our clinicians. If they choose to prescribe Mounjaro, this is passed to our pharmacy team, who prepare and post your treatment.
What is Mounjaro?
Mounjaro is a weekly injectable medication designed to help you achieve sustainable weight loss. Its active ingredient, tirzepatide, activates two essential hormonal receptors: GIP and GLP-1. These receptors play a crucial role in regulating appetite, blood sugar levels, and the rate at which food leaves your stomach.
| 2.5mg £250 | 5mg £275 | 7.5mg £350 |
| 10.mg £500 | 12.5mg £550 | 15mg £575 |
How Does Mounjaro Work?
- Appetite Suppression: Mounjaro curbs your cravings, making it easier to resist unhealthy snacks and overeating.
- Feeling Fuller for Longer: By mimicking GLP-1, Mounjaro helps you feel satisfied after meals, reducing the urge to snack between them.
- Slowing Down Gastric Emptying: Mounjaro slows down the rate at which food leaves your stomach, promoting better digestion and prolonged satiety.
Why Choose Mounjaro?
- Proven Effectiveness: In a clinical trial spanning 72 weeks, 96% of participants taking Mounjaro (at the highest dose) lost 5% or more of their initial body weight.
- Manufacturer: Mounjaro is manufactured by the reputable North American company, Eli Lilly.
- Safety: Mounjaro has been rigorously tested and approved for weight loss management.
- Clinical evidence: Researchers have shown that Mounjaro can significantly lower weight in people with obesity. In a study of more than 2,500 adults with obesity, individuals taking 5 milligrams of Mounjaro for 72 weeks (about a year and a half) lost an average of 15% of their body weight. Higher doses were associated with even more weight loss.
Why Choose Mounjaro?
- Proven Effectiveness: In a clinical trial spanning 72 weeks, 96% of participants taking Mounjaro (at the highest dose) lost 5% or more of their initial body weight.
- Manufacturer: Mounjaro is manufactured by the reputable North American company, Eli Lilly.
- Safety: Mounjaro has been rigorously tested and approved for weight loss management.
- Clinical evidence: Researchers have shown that Mounjaro can significantly lower weight in people with obesity. In a study of more than 2,500 adults with obesity, individuals taking 5 milligrams of Mounjaro for 72 weeks (about a year
Who cannot get Mounjaro?
- You may be unsuitable for this slimming injection if you:
- Have any known allergies to ingredients in it
- Are breastfeeding, pregnant or planning to conceive
- Are over 75 years old or under 18 years
- Have severe heart failure
- Have diabetes and currently take other medications containing GLP-1 (lixisenatide or exenatide) or have hypoglycaemia (low blood sugar)
- Have severe gut or stomach problems like inflammatory bowel disease or gastroparesis (delayed stomach emptying)
- Have severe kidney or liver disease or on dialysis
Ensure you mention to your weight loss doctor the following conditions:
- Pancreatic diseases
- Diabetes
- Gallstones or inflamed gallbladder
- A racing heart or heart palpitations
- Thyroid diseases, including enlargement of the thyroid gland and thyroid nodules
- Mild to moderate kidney or liver disease
- A condition requiring you to take anticoagulants such as warfarin
- Inflamed gallstones or gallbladder
Included in our protocol, is screening for the above, so when you access our service, we will assess you to ensure safety of these medications.
Dosage and Administration
Begin with 2.5mg of Mounjaro
The starting dose is 2.5 mg once a week for four weeks. After four weeks your doctor will increase your dose to 5 mg once a week.
Maintenance Dose
Gradually increase the dosage in 2.5mg increments until reaching the optimal dose of 15mg
Where should I inject Mounjaro
This is a subcutaneous injection, meaning you inject it under the skin. The recommended sites for taking the dose are the thigh, upper arm, or abdomen. Ensure you rotate the injection site every week to avoid skin irritation or other kinds of reactions on the area.
The following are guidelines for each injection site:
Abdomen
Inject it into the fatty tissues on either side of your navel but avoid the areas around your waistband or where the skin is damaged, bruised, tender, or scarred.
Thigh
It can be done into the fatty tissues on the front of the thigh, between the knee and hip. Ensure the injection area is at least 10cm or 4 inches above the knee.
Upper arm
It is possible into the fatty tissues between the shoulder and elbow, on the back of the upper arm, and at least 5cm or 2 inches below the shoulder
Although this product needs to be stored in the fridge, however it may be stored unrefrigerated for up to 30 days at a temperature not above 30 degrees, after which it must be discarded.
What are the side effects of Mounjaro?
Mounjaro has some common side effects, including:
- Nausea
- Vomiting
- Constipation
- Diarrhoea
Most Mounjaro side effects aren’t severe, and it is most common for side effects to occur when starting or increasing your dose
COMING SOON Retatrutide Injectons
Retatrutide (Triple G)
Eli Lilly, same manufacters of Mounjaro has developed Retatrutide, a new weight loss medicine. As the only injection to support weight loss in three ways,
Eli Lilly, same manufacters of Mounjaro has developed Retatrutide, a new weight loss medicine. As the only injection to support weight loss in three ways.
Dubbed ‘triple g,’ the once-weekly injection targets three key hormones that influence appetite and metabolism, making it more potent than Ozempic, which targets one, and Mounjaro, which targets two.
FAQS (Frequently Asked Question)
Retatrutide has been nicknamed ‘Triple G’. This is because it targets three different receptors and hormones – GLP-1, glucagon and GIP (1). Glucagon and GIP are naturally released when you eat food, and play a role in reducing appetite, lowering blood sugar, and helping the body burn fat (1).
This means Retatrutide can support people to reduce weight in three ways:
- Suppress appetite and slow digestion, meaning you’re not as hungry as often and feel fuller for longer
- Increase fat metabolism, so your body breaks down fat quicker
- Increase insulin sensitivity, which reduces blood sugar, causing the body to break down stored fat
The two medicines are similar, but they aren’t the same thing. Mounjaro injections work by acting like two hormones: GLP-1 and GIP. Whereas retatrutide brings on the effects of three: GLP-1, GIP, and GCG. This suggests that retatrutide is the stronger medicine.
Currently, Wegovy and Mounjaro injections are available to support weight loss.
Whilst Wegovy targets GLP-1 and Mounjaro targets GLP-1 and GIP (4), neither target glucagon receptors. This means that retatrutide, with three targets, could be more effective (1).
Testing has already shown that Retatrutide can help participants lose more weight in a shorter amount of time (1). Studies show that Retatrutide has achieved 24% weight loss in less than a year (48 weeks) (1). This is the highest percentage weight loss ever recorded in a trial for an obesity drug.
Over a longer period of time (72 weeks), Mounjaro has shown a 22% loss in weight, and Wegovy has shown 17% (4).
Retatrutide is given using a pen injector (1). It is delivered as a subcutaneous injection into the arm, thigh, or stomach (1). It is expected to be administered weekly, starting with a lower dose to minimise side effects (1)
Retatrutide has some common side effects (1), similar to Wegovy and Mounjaro, including:
- Nausea
- Vomiting
- Constipation
- Diarrhoea
Since retatrutide can help increase weight loss in an additional way to Wegovy and Mounjaro, these side effects could be more intense (1). They can be managed by using the injection when you eat, drinking plenty of water, and getting enough fibre in your diet (6).
Always consult your doctor, nurse or pharmacist before using any new medication.
Retatrutide® 40mg Injection Pen Kit contains 1 pen, 12 disposable needles and an instruction booklet.
Each pen has 40mg which can be delivered across 4 full doses of 10mg, or in increments of 2.5mg, 5mg, 7.5mg or 10mg.
Recommended dosage is 2.5mg for the first 4 weeks, then 5mg for the next 4 weeks. After 8 weeks the weekly dosage may be increased to 7.5mg 10mg if necessary.
Synedica Retatrutide® Injection Pen Kit is the world’s most advanced weight loss solution. Tirzepatide is an advanced medication which suppresses appetite leading to significant weight loss. It does this by mimicking the effects of GLP-1, GIP and natural hormones that makes humans feel full from eating much smaller portions of food. The Synedica Retatrutide® Injection Pen Kit will last the average new user 12 weeks.
By feeling full through the day users can experience fast and lasting fat loss without the normal hunger cravings of a traditional diet.
Most common side effects are nausea, jaw ache, and depression. For a full list of common and uncommon potential side effects see the booklet enclosed.
1 pen, 12 disposable 32g 4mm needles and an instruction booklet.
One kit which normally last 12 weeks for new users to semaglutide costs 600 euros from private pharmacies but is available free under certain employer health policies and for German citizens who qualify under Gesetzliche Krankenversicherung.
Currently Synedica Retatrutide® Injection Pen Kits are only available with a prescription in Germany from private clinics.
All new users should always start with semaglutide, then if necessary switch to tirzepatide and then retatrutide. The body will naturally build up an tolerance over time which is why the dose must be increased. Semaglutide effects 1 receptor in the body, but tirzepatide effect 2 receptors will be be very effective in users in a small dose who have built up a tolerance to semaglutide on the higher doses. Retatrutide effects 3 receptors so is perfect for users if a tolerance to the higher doses of tirzepatide has developed